Henry Li

2.9k total citations
38 papers, 847 citations indexed

About

Henry Li is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Henry Li has authored 38 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Genetics and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Henry Li's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Hemophilia Treatment and Research (6 papers) and Vitamin K Research Studies (3 papers). Henry Li is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Hemophilia Treatment and Research (6 papers) and Vitamin K Research Studies (3 papers). Henry Li collaborates with scholars based in United States, Australia and Canada. Henry Li's co-authors include Robert Lindblad, A.P. Khattignavong, David H. Broide, John T. Schroeder, Susan Balcer-Whaley, Robert G. Hamilton, Robert L. Coffman, Peter S. Creticos, Vicki L. Seyfert and Joseph Eiden and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Henry Li

32 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry Li United States 11 330 322 237 177 136 38 847
Geunwoong Noh South Korea 18 266 0.8× 422 1.3× 23 0.1× 342 1.9× 252 1.9× 54 920
Harry S. Earl United States 7 194 0.6× 497 1.5× 59 0.2× 452 2.6× 223 1.6× 9 1.0k
Paul Rouzaire France 16 191 0.6× 470 1.5× 26 0.1× 336 1.9× 266 2.0× 78 1.1k
Mitsuhiko Nambu Japan 12 201 0.6× 145 0.5× 18 0.1× 165 0.9× 115 0.8× 44 576
Carsten Sand Denmark 19 142 0.4× 179 0.6× 24 0.1× 90 0.5× 310 2.3× 39 893
L.S. OSTLERE United Kingdom 18 114 0.3× 92 0.3× 37 0.2× 62 0.4× 453 3.3× 70 953
Jiong Yang China 20 498 1.5× 123 0.4× 41 0.2× 483 2.7× 94 0.7× 61 1.2k
Jarosław Bogaczewicz Poland 12 66 0.2× 82 0.3× 23 0.1× 117 0.7× 215 1.6× 49 573
Gordon Raphael United States 16 677 2.1× 455 1.4× 35 0.1× 115 0.6× 59 0.4× 29 1.1k
Stéphane Kirkesseli United States 11 851 2.6× 335 1.0× 26 0.1× 354 2.0× 140 1.0× 16 1.3k

Countries citing papers authored by Henry Li

Since Specialization
Citations

This map shows the geographic impact of Henry Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Li more than expected).

Fields of papers citing papers by Henry Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Li. The network helps show where Henry Li may publish in the future.

Co-authorship network of co-authors of Henry Li

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Li. A scholar is included among the top collaborators of Henry Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Li. Henry Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacobs, Joshua, Adil Adatia, Timothy Craig, et al.. (2025). Treatment with Navenibart (STAR-0215) Reduces Attack Severity and Use of Rescue Medication in Patients with Hereditary Angioedema (HAE): Interim Results from the ALPHA-STAR Trial. Journal of Allergy and Clinical Immunology. 155(2). AB196–AB196.
2.
Li, Zijie, Henry Li, Yichun Shi, et al.. (2025). Dual Diffusion for Unified Image Generation and Understanding. 2779–2790.
3.
Nguyen, Kevin H., Richard Khor, Sweet Ping Ng, et al.. (2024). Incidence and Factors Associated With the Development of Calvarial Osteoradionecrosis in Patients Treated for Cutaneous Malignancies. Craniomaxillofacial Trauma & Reconstruction. 17(4). NP51–NP59.
4.
Lumry, William R., Timothy Craig, John Anderson, et al.. (2023). Patient outcomes associated with subcutaneous C1INH prophylaxis for hereditary angioedema: a retrospective analysis. Allergy Asthma and Clinical Immunology. 19(1). 105–105. 3 indexed citations
5.
Alpan, Oral, Richard L. Wasserman, Amy Darter, et al.. (2023). Towards an FDA-cleared basophil activation test. SHILAP Revista de lepidopterología. 3. 1009437–1009437. 12 indexed citations
6.
Simner, Patricia J., Kimberlee A. Musser, Kara Mitchell, et al.. (2022). Multicenter Evaluation of the Acuitas AMR Gene Panel for Detection of an Extended Panel of Antimicrobial Resistance Genes among Bacterial Isolates. Journal of Clinical Microbiology. 60(3). e0209821–e0209821. 6 indexed citations
7.
Li, Henry, et al.. (2022). Elucidating a Silent Illness: Hepatitis B Knowledge Among Asian Individuals in an Urban Center. Journal of Public Health Management and Practice. 28(4). 417–424. 1 indexed citations
8.
An, Xiaoyu, Henry Li, Faming Zhang, et al.. (2022). 491 Preclinical pharmacology modeling of HX009, a clinical stage first-in-class PD-1xCD47 BsAb, for anti-lymphoma applications. Regular and Young Investigator Award Abstracts. A512–A512. 1 indexed citations
9.
10.
Rong, Haojing, Kirti Sharma, Bin Yang, et al.. (2020). Mechanisms of the Anti-Tumor Activity of STAT3 Degraders in Lymphoma. Blood. 136(Supplement 1). 42–42.
11.
Li, Henry, et al.. (2019). Comparative osteoradionecrosis rates in bony reconstructions for head and neck malignancy. Journal of Plastic Reconstructive & Aesthetic Surgery. 72(9). 1478–1483. 5 indexed citations
12.
Craig, Timothy, Paula J. Busse, Richard Gower, et al.. (2018). Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency. Annals of Allergy Asthma & Immunology. 121(6). 673–679. 22 indexed citations
13.
Li, Henry, et al.. (2017). Searching for a written patient feedback instrument for patient–medical student consultations. Advances in Medical Education and Practice. Volume 8. 171–178. 7 indexed citations
14.
Salman, David, et al.. (2017). Imaging the lung: the old ways and the new.. PubMed. 32(4). 325–337. 5 indexed citations
15.
Banerji, Aleena, Paula J. Busse, Sandra C. Christiansen, et al.. (2015). Current state of hereditary angioedema management: A patient survey. Allergy and Asthma Proceedings. 36(3). 213–217. 78 indexed citations
16.
Wu, Yan, Zhaojing Zhong, Stella Martomo, et al.. (2015). Abstract C173: Anti-PD-L1 antibody-based IL-15 immunocytokine has enhanced antitumor immunity. Molecular Cancer Therapeutics. 14(12_Supplement_2). C173–C173. 1 indexed citations
17.
Riedl, Marc A., Jonathan A. Bernstein, Henry Li, et al.. (2014). Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. Annals of Allergy Asthma & Immunology. 112(2). 163–169.e1. 60 indexed citations
18.
Bernstein, Jonathan A., Michael Manning, Henry Li, et al.. (2013). Escalating Doses of C1 Esterase Inhibitor (CINRYZE) for Prophylaxis in Patients With Hereditary Angioedema. The Journal of Allergy and Clinical Immunology In Practice. 2(1). 77–84.e1. 39 indexed citations
19.
Creticos, Peter S., John T. Schroeder, Robert G. Hamilton, et al.. (2006). Immunotherapy with a Ragweed–Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis. New England Journal of Medicine. 355(14). 1445–1455. 438 indexed citations
20.
White, Martha V., et al.. (2006). Effects of long-term inhaled corticosteroids on adrenal function in patients with asthma. Annals of Allergy Asthma & Immunology. 96(3). 437–444. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geunwoong Noh Breakdown of academic impact, for papers by Harry S. Earl Breakdown of academic impact, for papers by Paul Rouzaire Breakdown of academic impact, for papers by Mitsuhiko Nambu Breakdown of academic impact, for papers by Carsten Sand Breakdown of academic impact, for papers by L.S. OSTLERE Breakdown of academic impact, for papers by Jiong Yang Breakdown of academic impact, for papers by Jarosław Bogaczewicz Breakdown of academic impact, for papers by Gordon Raphael Breakdown of academic impact, for papers by Stéphane Kirkesseli
Rankless by CCL
2026